Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai

G. Zou, X Wei, Sophie Witter, J. Yin, J. Walley, S Liu, H. Yang, J Chen, G Tian, J. Mei

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

SETTING: Two projects were introduced in October 2007 to improve treatment completion among rural-to-urban migrant tuberculosis (TB) patients in Shanghai. The Communicable Disease Research Consortium (COMDIS) project provided financial incentives to poor patients, whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) project provided incentives to all patients and increased staff time.
OBJECTIVE: To assess the incremental cost-effectiveness of these two projects.
METHODS: Case study. Costs were assessed from a societal perspective. The primary measure of effectiveness was the treatment completion rate. The incremental cost-effectiveness ratio was calculated as the additional cost of the intervention divided by the additional percentage of patients completing treatment compared to controls.
RESULTS: Post intervention, the treatment completion rates in the COMDIS and Global Fund projects were respectively 89% and 88%, 17% and 16% higher than in the control district (76%). For one additional per cent of patients to complete treatment, the additional cost of the COMDIS intervention was US$1891, 91% lower than that of the Global Fund intervention (US$21 904).
CONCLUSION: The intervention that addressed the financial barriers of poor patients was more cost-effective than the comprehensive intervention that provided assistance to both patients and providers. Further study is needed to understand the process of interventions prior to wider scale-up.
Original languageEnglish
Pages (from-to)1056-1064
Number of pages9
JournalInternational Journal of Tuberculosis and Lung Disease
Volume17
Issue number8
DOIs
Publication statusPublished - 1 Aug 2013

Fingerprint

Cost-Benefit Analysis
Tuberculosis
Communicable Diseases
Costs and Cost Analysis
Therapeutics
Motivation
Research
Cost of Illness
Health Care Costs
Malaria
Acquired Immunodeficiency Syndrome

Keywords

  • tuberculosis
  • cost effectiveness
  • China
  • migrants
  • incentives
  • financial incentives
  • treatment completion
  • economic evaluation

Cite this

Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai. / Zou, G. ; Wei, X ; Witter, Sophie; Yin, J. ; Walley, J. ; Liu, S ; Yang, H.; Chen, J; Tian, G; Mei, J. .

In: International Journal of Tuberculosis and Lung Disease, Vol. 17, No. 8, 01.08.2013, p. 1056-1064 .

Research output: Contribution to journalArticle

Zou, G. ; Wei, X ; Witter, Sophie ; Yin, J. ; Walley, J. ; Liu, S ; Yang, H. ; Chen, J ; Tian, G ; Mei, J. . / Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai. In: International Journal of Tuberculosis and Lung Disease. 2013 ; Vol. 17, No. 8. pp. 1056-1064 .
@article{319347681c864723b5f912d19e832834,
title = "Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai",
abstract = "SETTING: Two projects were introduced in October 2007 to improve treatment completion among rural-to-urban migrant tuberculosis (TB) patients in Shanghai. The Communicable Disease Research Consortium (COMDIS) project provided financial incentives to poor patients, whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) project provided incentives to all patients and increased staff time.OBJECTIVE: To assess the incremental cost-effectiveness of these two projects.METHODS: Case study. Costs were assessed from a societal perspective. The primary measure of effectiveness was the treatment completion rate. The incremental cost-effectiveness ratio was calculated as the additional cost of the intervention divided by the additional percentage of patients completing treatment compared to controls.RESULTS: Post intervention, the treatment completion rates in the COMDIS and Global Fund projects were respectively 89{\%} and 88{\%}, 17{\%} and 16{\%} higher than in the control district (76{\%}). For one additional per cent of patients to complete treatment, the additional cost of the COMDIS intervention was US$1891, 91{\%} lower than that of the Global Fund intervention (US$21 904).CONCLUSION: The intervention that addressed the financial barriers of poor patients was more cost-effective than the comprehensive intervention that provided assistance to both patients and providers. Further study is needed to understand the process of interventions prior to wider scale-up.",
keywords = "tuberculosis, cost effectiveness, China, migrants, incentives, financial incentives, treatment completion, economic evaluation",
author = "G. Zou and X Wei and Sophie Witter and J. Yin and J. Walley and S Liu and H. Yang and J Chen and G Tian and J. Mei",
year = "2013",
month = "8",
day = "1",
doi = "10.5588/ijtld.12.0799",
language = "English",
volume = "17",
pages = "1056--1064",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)",
number = "8",

}

TY - JOUR

T1 - Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai

AU - Zou, G.

AU - Wei, X

AU - Witter, Sophie

AU - Yin, J.

AU - Walley, J.

AU - Liu, S

AU - Yang, H.

AU - Chen, J

AU - Tian, G

AU - Mei, J.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - SETTING: Two projects were introduced in October 2007 to improve treatment completion among rural-to-urban migrant tuberculosis (TB) patients in Shanghai. The Communicable Disease Research Consortium (COMDIS) project provided financial incentives to poor patients, whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) project provided incentives to all patients and increased staff time.OBJECTIVE: To assess the incremental cost-effectiveness of these two projects.METHODS: Case study. Costs were assessed from a societal perspective. The primary measure of effectiveness was the treatment completion rate. The incremental cost-effectiveness ratio was calculated as the additional cost of the intervention divided by the additional percentage of patients completing treatment compared to controls.RESULTS: Post intervention, the treatment completion rates in the COMDIS and Global Fund projects were respectively 89% and 88%, 17% and 16% higher than in the control district (76%). For one additional per cent of patients to complete treatment, the additional cost of the COMDIS intervention was US$1891, 91% lower than that of the Global Fund intervention (US$21 904).CONCLUSION: The intervention that addressed the financial barriers of poor patients was more cost-effective than the comprehensive intervention that provided assistance to both patients and providers. Further study is needed to understand the process of interventions prior to wider scale-up.

AB - SETTING: Two projects were introduced in October 2007 to improve treatment completion among rural-to-urban migrant tuberculosis (TB) patients in Shanghai. The Communicable Disease Research Consortium (COMDIS) project provided financial incentives to poor patients, whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) project provided incentives to all patients and increased staff time.OBJECTIVE: To assess the incremental cost-effectiveness of these two projects.METHODS: Case study. Costs were assessed from a societal perspective. The primary measure of effectiveness was the treatment completion rate. The incremental cost-effectiveness ratio was calculated as the additional cost of the intervention divided by the additional percentage of patients completing treatment compared to controls.RESULTS: Post intervention, the treatment completion rates in the COMDIS and Global Fund projects were respectively 89% and 88%, 17% and 16% higher than in the control district (76%). For one additional per cent of patients to complete treatment, the additional cost of the COMDIS intervention was US$1891, 91% lower than that of the Global Fund intervention (US$21 904).CONCLUSION: The intervention that addressed the financial barriers of poor patients was more cost-effective than the comprehensive intervention that provided assistance to both patients and providers. Further study is needed to understand the process of interventions prior to wider scale-up.

KW - tuberculosis

KW - cost effectiveness

KW - China

KW - migrants

KW - incentives

KW - financial incentives

KW - treatment completion

KW - economic evaluation

U2 - 10.5588/ijtld.12.0799

DO - 10.5588/ijtld.12.0799

M3 - Article

VL - 17

SP - 1056

EP - 1064

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 8

ER -